Profit margins for U.S. home health agencies have been in free-fall over the past four years, compromising large, publicly traded companies and putting smaller providers in even more serious jeopardy. In 2010, the full-year margin for four of the largest home health companies averaged 7.1%, according to an Avalere Health analysis released Thursday by the Partnership for […]
Almost Family
Despite favorable demographics driving home health demand, some of the nation’s largest home health companies have been beset by problems in recent years. But it appears the tide may be turning, as many of these companies posted good results for the start of 2015 — and Wall Street analysts have responded accordingly. One such company, Amedisys, […]
Almost Family Appoints Former U.S. Tech Officer to Board of Directors Almost Family, Inc. (NASDAQ: AFAM), a Louisville, Ky.-based national provider of home health and nursing services, this week appointed Annesh Chopra a new board member. Chopra is the former U.S. Chief Technology Officer under President Barack Obama. Co-founder of NavHealth and Hunch Analytics, Chopra […]
As one of the fastest-growing sectors in the United States, home health care is teeming with business activity. Here are some of the industry’s latest investments, acquisitions and partnerships: Strategic Partnership Creates Documentation, Quality Solution For Agencies Jacksonville, Florida-based Forcura and Floral Park, New York-based Quality In Real Time (QIRT) have announced a new strategic […]
Almost Family (Nasdaq: AFAM) is significantly expanding its personal care offerings by acquiring WillCare HealthCare in a roughly $50 million deal, the company announced Wednesday. With the addition of WillCare, Louisville-based Almost Family is increasing the size of its personal care segment by nearly one-third, to an expected $150 million in annual revenue, according to […]
Home health care provider Almost Family (NASDAQ:AFAM) saw its net income decline 8.1% to $4.55 million, or $0.49 per diluted share, in the second quarter ended June 30, 2012, compared to the previous year’s $4.95 million, or $0.53 per diluted share, attributed in part to decreases in Medicare reimbursement rates. “We’re pleased with our results […]